Clinical Trial Update: Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing celecoxib to naproxen for preventing recurrent ulcer bleeding in arthritis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Cardiovascular Diseases
• Cerebrovascular Disorders

Drugs mentioned

• Celecoxib (Celecoxib)
• Naproxen (Naproxen)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Arthritis, Cardiovascular Diseases | Phase 3 | Status: COMPLETED